Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24031900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ying Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study.
Abstract (Originalsprache)
The Zika virus (ZIKV) epidemic poses a significant threat to human health globally. Thus, there is an urgent need for developing effective anti-ZIKV agents. ZIKV non-structural protein 5 RNA-dependent RNA polymerase (RdRp), a viral enzyme for viral replication, has been considered an attractive drug target. In this work, we screened an anti-infection compound library and a natural product library by virtual screening to identify potential candidates targeting RdRp. Then, five selected candidates were further applied for RdRp enzymatic analysis, cytotoxicity, and binding examination by SPR. Finally, posaconazole (POS) was confirmed to effectively inhibit both RdRp activity with an IC50 of 4.29 μM and the ZIKV replication with an EC50 of 0.59 μM. Moreover, POS was shown to reduce RdRp activity by binding with the key amino acid D666 through molecular docking and site-directed mutation analysis. For the first time, our work found that POS could inhibit ZIKV replication with a stronger inhibitory activity than chloroquine. This work also demonstrated fast anti-ZIKV screening for inhibitors of RdRp and provided POS as a potential anti-ZIKV agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Förderung
- CAMS Innovation Fund for Medical Sciences
- Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study
Zitieren
APA
Chen, Y., Chi, X., Zhang, H., Zhang, Y., Qiao, L., Ding, J., Han, Y., Lin, Y., & Jiang, J. (2023). Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24031900
Vancouver
Chen Y, Chi X, Zhang H, Zhang Y, Qiao L, Ding J, et al. Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24031900
BibTeX
@article{Chen2023,
author = {Chen, Ying and Chi, Xiangyin and Zhang, Hongjuan and Zhang, Yu and Qiao, Luyao and Ding, Jinwen and Han, Yanxing and Lin, Yuan and Jiang, Jiandong},
title = {Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24031900}
}
EUVIMED